An Operant Conditioning Model to Assess Changes in Feeding Behavior Associated with Temporomandibular Joint Inflammation in the Rat

Aims: To develop and validate a model in which to assess a loss of function associated with temporomandibular joint (TMJ) inflammation in awake, freely moving rats. Methods: The dependent variable in the model was the time between food rewards (pellets), or interfeeding interval (IFI). IFI was quantified after rats were trained to “bar-press” for food. To validate use of the IFI as a surrogate for temporomandibular disorder (TMD) pain, we determined the impact of several manipulations, including changes in pellet size, the presence and severity of inflammation of the TMJ, masseter muscle, or skin (induced with complete Freund’s adjuvant [CFA]), and the influence of preadministration of the nonsteroidal anti-inflammatory drug indomethacin (4 mg/kg). Furthermore, in order to determine whether a change in IFI reflected an increase in the time rats spent eating, rats were videotaped, and the amount of time spent eating, grooming, and exploring was analyzed. Results: Inflammation of the TMJ or masseter muscle resulted in significant dose- and pellet size–dependent increases in the IFI. Inflammation of the skin overlying the TMJ had no effect on IFI. Pre-administration of indomethacin reversed the inflammation-induced shift in the IFI. An inflammation-induced increase in IFI was associated with an increase in feeding time. Conclusions: Our model constitutes a relatively fast and sensitive method with which to assess changes in feeding behavior associated with TMJ inflammation. Only 2 days of training are required to obtain a stable baseline IFI. It is possible to detect changes in IFI as small as 40% with 12 rats per group.

inflammation; nociception; pain; temporomandibular joint disorders

1. Sarlani E, Greenspan JD. Why look in the brain for answers to temporomandibular disorder pain? Cells Tissues Organs 2005;180:69–75.

2. Svensson P, Arendt-Nielson L. Clinical and experimental aspects of temporomandibular disorders. Curr Rev Pain 2000;4:158–165.

3. Greene CS. The etiology of temporomandibular disorders: Implications for treatment. J Orofac Pain 2001;15: 93–105.

4. Di Paolo C, Panti F, Crocitto P, De Luca M. Long term follow-up of patients affected by temporomandibular joint dysfunction treated with orthodontic and/or prosthetic occlusal therapy. Minerva Stomatol 2004;53:5555–5570.

5. Suvinen TI, Reade PC, Kemppainen P, Kononen M, Dworkin SF. Review of aetiological concepts of temporomandibular pain disorders: Towards a biopsychosocial model for integration of physical disorder factors with psychological and psychosocial illness impact factors. Eur J Pain 2005;9:613–633.

6. Gesch D, Bernhardt O, Mack F, John U, Kocher T, Alte

D. Association of malocclusion and functional occlusion with subjective symptoms of TMD in adults: Results of the Study of Health in Pomerania (SHIP). Angle Orthod 2005;75:183–190.

7. Ren K. An improved method for assessing mechanical allodynia in the rat. Physiol Behav 1999;67:711–716.

8. Imbe H, Iwata K, Zhou QQ, Zou S, Dubner R, Ren K. Orofacial deep and cutaneous tissue inflammation and trigeminal neuronal activation. Implications for persistent temporomandibular pain. Cells Tissues Organs 2001;169: 238–247.

9. Schutz TC, Andersen ML, Tufik S. Influence of temporomandibular joint pain on sleep patterns: Role of nitric oxide. J Dent Res 2004;83:693–697.

10. Schutz TC, Andersen ML, Tufik S. Sleep alterations in an experimental orofacial pain model in rats. Brain Res 2003;993:164–171.

11. Roveroni RC, Parada CA, Cecilia M, Veiga FA, Tambeli CH. Development of a behavioral model of TMJ pain in rats: The TMJ formalin test. Pain 2001;94:185–191.

12. Clemente JT, Parada CA, Veiga MC, Gear RW, Tambeli CH. Sexual dimorphism in the antinociception mediated by kappa opioid receptors in the rat temporomandibular joint. Neurosci Lett 2004;372:250–255.

13. Hartwig AC, Mathias SI, Law AS, Gebhart GF. Characterization and opioid modulation of inflammatory temporomandibular joint pain in the rat. J Oral Maxillofac Surg 2003;61:1302–1309.

14. Ro JY, Capra N, Masri R. Development of a behavioral assessment of craniofacial muscle pain in lightly anesthetized rats. Pain 2003;104:179–185.

15. Ro JY. Bite force measurement in awake rats: A behavioral model for persistent orofacial muscle pain and hyperalgesia. J Orofac Pain 2005;19:159–167.

16. Kerins CA, Carlson DS, Hinton RJ, et al. Specificity of meal pattern analysis as an animal model of determining temporomandibular joint inflammation/pain. Int J Oral Maxillofac Surg 2005;34:425–431.

17. Kerins C, Carlson D, McIntosh J, Bellinger L. A role for cyclooxygenase II inhibitors in modulating temporomandibular joint inflammation from a meal pattern analysis perspective. J Oral Maxillofac Surg 2004;62:989–995.

18. Kerins CA, Carlson DS, McIntosh JE, Bellinger LL. Meal pattern changes associated with temporomandibular joint inflammation/pain in rats; analgesic effects. Pharmacol Biochem Behav 2003;75:181–189.

19. Harper RP, Kerins CA, Talwar R, et al. Meal pattern analysis in response to temporomandibular joint inflammation in the rat. J Dent Res 2000;79:1704–1711.

20. Thut PD, Flake NM, Hermanstyne TO, Gold MS. An operant conditioning model with which to assess temporomandibular pain. Abstract presented at the 29th Scientific Annual Meeting of the American Academy of Orofacial Pain, San Francisco, 25–28 March 2004.

21. Flake NM, Bonebreak DB, Gold MS. Estrogen and inflammation increase the excitability of rat temporomandibular joint afferent neurons. J Neurophysiol 2005;93:1585–1597.

22. Zhang RX, Lao L, Wang X, Ren K, Berman BB. Electroacupuncture combined with indomethacin enhances antihyperalgesia in inflammatory rats. Pharmacol Biochem Behav 2004;78:793–797.

23. Carr J, Wilhelm DL. The evaluation of increased vascular permeability in the skin of guinea pigs. Aust J Exp Biol Med Sci 1964;42:511–522.

24. Dessem D. Interactions between jaw-muscle recruitment and jaw-joint forces in Canis familiaris. J Anat 1989;164:101–121.

25. Okeson J. Management of TMD and Occlusion. St Louis: Mosby, 2003.

26. Schaible HG, Ebersberger A, Von Banchet GS. Mechanisms of pain in arthritis. Ann N Y Acad Sci 2002; 966:343–354.

27. Xie G, Wang Y, Sharma M, et al. 5-Hydroxytryptamine-induced plasma extravasation in the rat knee joint is mediated by multiple prostaglandins. Inflamm Res 2003;52:32–38.

28. Gimeno G, Carpentier PH, Desquand-Billiald S, Finet M, Hanf R. Respective role of lipoxygenase and nitric oxidesynthase pathways in plasma histamine-induced macromolecular leakage in conscious hamsters. Br J Pharmacol 1999;126:1801–1809.

29. Damas J, Liegeois JF. The inflammatory reaction induced by formalin in the rat paw. Naunyn Schmiedebergs Arch Pharmacol 1999;359:220–227.

30. Campbell EA, Gentry C, Patel S, et al. Oral anti-hyperalgesic and anti-inflammatory activity of NK(1) receptor antagonists in models of inflammatory hyperalgesia of the guinea-pig. Pain 2000;87:253–263.

31. McNeill C, Dubner R. What is pain and how do we classify orofacial pain? In: Lund JP, Lavigne GJ, Dubner R, Sessle BJ (eds). Orofacial Pain: From Basic Science to Clinical Management. Chicago: Quintessence, 2001:3–14.

32. Broussard JS Jr. Derangement, osteoarthritis, and rheumatoid arthritis of the temporomandibular joint: Implications, diagnosis, and management. Dent Clin North Am 2005;49:327–342.

33. Dworkin SF, LeResche L (eds). Research Diagnostic Criteria for Temporomandibular Disorders: Review, criteria, examinations and specifications, critique. J Craniomandib Disord 1992;6:301–355.

34. Lobbezoo F, Drangsholt M, Peck C, Sato H, Kopp S, Svensson P. Topical review: New insights into the pathology and diagnosis of disorders of the temporomandibular joint. J Orofac Pain 2004;18:181–191.

35. Pereira FJ, Lundh H, Eriksson L, Westesson PL. Microscopic changes in the retrodiscal tissues of painful temporomandibular joints. J Oral Maxillofac Surg 1996;54:461–468.

36. Murakami K, Segami N, Fujimura K, Iizuka T. Correlation between pain and synovitis in patients with internal derangement of the temporomandibular joint. J Oral Maxillofac Surg 1991;49:1159–1161.

37. List T, Axelsson S, Leijon G. Pharmacologic interventions in the treatment of temporomandibular disorders, atypical facial pain, and burning mouth syndrome. A qualitative systematic review. J Orofac Pain 2003;17:301–310.

38. Ta LE, Neubert JK, Dionne R. Pharmacological treatments for temporomandibular disorders and other orofacial pain. In: Dionne R, Phero J, Becker D (eds). Management of Pain and Anxiety in the Dental Office. New York: Saunders, 2002:354–367.